Uric acid in Parkinson's disease

@article{Schlesinger2008UricAI,
  title={Uric acid in Parkinson's disease},
  author={Ilana Schlesinger and Naomi Schlesinger},
  journal={Movement Disorders},
  year={2008},
  volume={23}
}
Recent studies have provided evidence that uric acid may play a role in the development and progression of Parkinson's disease (PD). Uric acid is a natural antioxidant that may reduce oxidative stress, a mechanism thought to play a role in the pathogenesis of PD. Higher levels of serum urate (SU) may have a neuroprotective effect. High SU levels reduced the risk of developing PD and correlated with slower PD progression. Among PD patients SU levels were lower as compared with controls. The… 
Serum Uric Acid and Nigral Iron Deposition in Parkinson’s Disease: A Pilot Study
TLDR
Serum UA levels were significantly decreased in patients with Parkinson’s disease and the data suggest that serum UA may not be important determinant of nigral iron deposition in PD, and the relationship between these two markers is failed.
Uric Acid as a Potential Peripheral Biomarker for Disease Features in Huntington’s Patients
TLDR
It is suggested that decreased levels of UA in the brains of HD patients can be reflected in peripheral fluids, with salivary measures of UA particularly offering significant promise as a potentially relevant, non-invasive biomarker of disease symptoms and burden.
Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype
TLDR
It is speculated that UA might be involved in the maintenance of the less damaging TD phenotype and thus also in the conversion from TD to PIGD, and therefore influence the conversion to a more severe motor phenotype.
The emerging role of nutrition in Parkinson's disease
TLDR
A review of studies that have addressed the role nutrition plays in both neuroprotection and neurodegeneration in Parkinson's disease and describes in detail the nutrients and their putative mechanisms of action in PD.
Serum Uric Acid in Patients with Parkinson’s Disease and Vascular Parkinsonism: A Cross-Sectional Study
TLDR
The hypothesis that subjects with low serum UA levels may be more prone to developing Parkinson’s disease is supported and the inverse relationship between UA and severity of PD was robust for men but weak for women.
state of uric acid in Iraqi patients with Parkinson disease
TLDR
The study's findings show that PD patients had much lower uric acid levels than healthy controls, and suggest that uric Acid may have a role in Parkinson's disease.
Association between serum uric acid and motor subtypes of Parkinson’s disease
Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathway.
TLDR
Analysis of clinical and biochemical analyses and analysis of three single nucleotide polymorphisms known to be associated with altered serum UA levels suggest an involvement of serum UA in LBD occurrence, and a involvement of CSF UA in cognitive decline in L BD, possibly through the Aβ pathway.
...
...

References

SHOWING 1-10 OF 54 REFERENCES
Low plasma uric acid level in Parkinson's disease
TLDR
Plasma uric acid level is low in patients with PD, which may have implications for both the disease pathogenesis and treatment recommendations, and there were no significant differences in the levels of plasma iron parameters.
Plasma urate and risk of Parkinson's disease.
TLDR
It is suggested that high plasma urate concentrations may decrease the risk of Parkinson's disease, and the possibility that interventions to increase Plasma urate may reduce the risk and delay the progression of Parkinson’s disease is raised.
Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease.
TLDR
Preliminary evidence of an association between uric acid and reduced occurrence of idiopathic Parkinson's disease is provided and indicates that further investigations of this association are warranted.
GOUT AND RISK OF PARKINSON DISEASE: A PROSPECTIVE STUDY
TLDR
The initiation of antigout medication is associated with a lower risk of developing Parkinson disease (PD), and an association with serum uric acid (UA) in neurodegenerative disorders such as PD, amyotrophic lateral sclerosis, and Alzheimer disease is determined.
[Case-control study of markers of oxidative stress and metabolism of blood iron in Parkinson's disease].
TLDR
The results of this study support the possible involvement of oxidative stress in the pathogenesis of Parkinson's disease and reveal alterations in some peripheral blood parameters in keeping with known findings in the sustantia nigra.
Oxidative Stress in Parkinson's Disease
TLDR
Should a similar multifactorial cascade underlie dopaminergic neuron degeneration in PD, then the optimal therapy for this disease may have to rely on a cocktail of agents, each targeting a different critical component of this hypothesized pathogenic cascade.
Serum uric acid levels and the risk of Parkinson disease
TLDR
The hypothesis that oxidative stress contributes to the risk of Parkinson disease is supported and a potential protective effect of the natural antioxidant and free radical scavenger uric acid is suggested.
Uric acid is reduced in the substantia nigra in parkinson's disease: Effect on dopamine oxidation
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease
TLDR
Analysis of several blood products relevant to oxidant stress, including malondialdehyde, 5‐S‐cysteinyl‐dopa, α‐tocophero, and uric acid, failed to distinguish patients with Parkinson's disease or dementia of Alzheimer's type from controls.
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease
TLDR
It is suggested that glutathione depletion, possibly consequent to overutilisation in oxidative stress reactions, could play a causal role in nigral degeneration in all nigrostriatal dopamine deficiency disorders, and that antioxidant therapeutic approaches should not be restricted to PD.
...
...